The daily impact of pain from metastatic breast cancer on spousal relationships: A dyadic electronic diary studyBADR, Hoda; LAURENCEAU, Jean-Philippe; SCHART, Leslie et al.Pain (Amsterdam). 2010, Vol 151, Num 3, pp 644-654, issn 0304-3959, 11 p.Article

Impact of chemotherapy beyond the first line in patients with metastatic breast cancerDUFRESNE, Armelle; PIVOT, Xavier; TOURNIGAND, Christophe et al.Breast cancer research and treatment. 2008, Vol 107, Num 2, pp 275-279, issn 0167-6806, 5 p.Article

Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancerSCHIPPINGER, Walter; REGITNIG, Peter; DANDACHI, Nadia et al.Virchows Archiv. 2006, Vol 449, Num 1, pp 24-30, issn 0945-6317, 7 p.Article

Associations between depression, pain behaviors, and partner responses to pain in metastatic breast cancerBADR, Hoda; MILBURY, Kathrin.Pain (Amsterdam). 2011, Vol 152, Num 11, pp 2596-2604, issn 0304-3959, 9 p.Article

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancerBOTTERI, Edoardo; SANDRI, Maria Teresa; SALVATICI, Michela et al.Breast cancer research and treatment. 2010, Vol 122, Num 1, pp 211-217, issn 0167-6806, 7 p.Article

Yoga for women with metastatic breast cancer : Results from a pilot studyCARSON, James W; CARSON, Kimberly M; PORTER, Laura S et al.Journal of pain and symptom management. 2007, Vol 33, Num 3, pp 331-341, issn 0885-3924, 11 p.Article

Metastatic breast cancer: are we treating the same patients as in the past?UFEN, M.-P; KÖHNE, C. H; WISCHNESWKY, M et al.Annals of oncology. 2014, Vol 25, Num 1, pp 95-100, issn 0923-7534, 6 p.Article

Third consensus on medical treatment of metastatic breast cancerBESLIJA, S; BONNETERRE, J; PETIT, T et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1771-1785, issn 0923-7534, 15 p.Article

Changing Indications for Surgery in Patients With Stage IV Breast Cancer : A Current PerspectiveMORROGH, Mary; PARK, Anna; NORTON, Larry et al.Cancer. 2008, Vol 112, Num 7, pp 1445-1454, issn 0008-543X, 10 p.Article

A Prospective Evaluation of the Durability of Palliative Interventions for Patients With Metastatic Breast CancerMORROGH, Mary; MINER, Thomas J; PARK, Anna et al.Cancer. 2010, Vol 116, Num 14, pp 3338-3347, issn 0008-543X, 10 p.Article

Circulating tumor cells in metastatic inflammatory breast cancerMEGO, M; DE GIORGI, U; HSU, L et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1824-1828, issn 0923-7534, 5 p.Article

Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published dataTARTARONE, A; ROMANO, G; GALASSO, R et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 7, pp 525-530, issn 0268-3369, 6 p.Article

Eribulin: A Novel Cytotoxic Chemotherapy AgentPRESTON, Jessica N; TRIVEDI, Meghana V.The Annals of pharmacotherapy. 2012, Vol 46, Num 6, pp 802-811, issn 1060-0280, 10 p.Article

Second consensus on medical treatment of metastatic breast cancerBESLIJA, S; BONNETERRE, J; MENARD, S et al.Annals of oncology. 2007, Vol 18, Num 2, pp 215-225, issn 0923-7534, 11 p.Article

The decision to prematurely terminate a trial of R-HuEPO due to thrombotic eventsROSENZWEIG, Margaret Q; BENDER, Catherine M; LUCKE, Joseph P et al.Journal of pain and symptom management. 2004, Vol 27, Num 2, pp 185-190, issn 0885-3924, 6 p.Article

An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patientsREGIERER, A. C; WOLTERS, R; UFEN, M. -P et al.Annals of oncology. 2014, Vol 25, Num 3, pp 633-638, issn 0923-7534, 6 p.Article

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancerSHERRILL, B; AMONKAR, M; WU, Y et al.British journal of cancer. 2008, Vol 99, Num 10, pp 1572-1578, issn 0007-0920, 7 p.Article

Management of advanced breast cancerORLANDO, L; COLLEONI, M; FEDELE, P et al.Annals of oncology. 2007, Vol 18, issn 0923-7534, vi74-vi76, SUP6Conference Paper

Optimizing the treatment of metastatic breast cancerGRALOW, Julie R.Breast cancer research and treatment. 2005, Vol 89, pp S9-S15, issn 0167-6806, SUP1Article

Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasisALL, S. M; DEMERS, L. M; SEAMAN, J et al.Annals of oncology. 2004, Vol 15, Num 3, pp 455-459, issn 0923-7534, 5 p.Article

A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancerKÜMLER, Iben; BRÜNNER, Nils; STENVANG, Jan et al.Breast cancer research and treatment. 2013, Vol 138, Num 2, pp 347-358, issn 0167-6806, 12 p.Article

The economic burden of metastatic breast cancer: a U.S. managed care perspectiveMONTERO, Alberto J; EAPEN, Sara; GORIN, Brian et al.Breast cancer research and treatment. 2012, Vol 134, Num 2, pp 815-822, issn 0167-6806, 8 p.Article

Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, SwedenFOUKAKIS, Theodoros; FORNANDER, Tommy; LEKBERG, Tobias et al.Breast cancer research and treatment. 2011, Vol 130, Num 2, pp 553-560, issn 0167-6806, 8 p.Article

Ixabepilone for the treatment of breast cancerALVAREZ, Ricardo H; VALERO, Vicente; HORTOBAGYI, Gabriel N et al.Annals of medicine (Helsinki). 2011, Vol 43, Num 5-6, pp 477-486, issn 0785-3890, 10 p.Article

Efficacy and Safety of S-1 in Patients with Metastatic Breast Cancer: Retrospective Review in a Single InstitutionHARA, Fumikata; KIYOTO, Sachiko; TAKAHASHI, Mina et al.Oncology. 2010, Vol 79, Num 3-4, pp 273-277, issn 0030-2414, 5 p.Article